The AiriCU series is a medical mesh nebulizer that can be used in combination with a ventilator for the nebulization of aerosols.
It facilitates the administration of medication at all stages of the patient's respiratory process(invasive mechanical ventilation, invasive ventilation, high flow, and self-ventilation).
Our technology
AiMesh is feellife's core nebulization technology patent matrix, as well as an internationally certified invention patent. By combining artificial intelligence algorithms with feellife's unique material, AiMesh redefines the nebulization industry.
Critical Care Nebulization Expert
With the vision of "The Third Way of Dosing" and the technology core of "AiMesh ®" polymer nebulizer, feellife owns more than 250+ international invention patents and certificates, taking the leading position in the field of nebulized drug delivery, and the clinical nebulization equipment for hospital intensive care represented by "AirICU" has already benefited millions of patients in more than 40 countries and regions.
50+
Doctors Recommended
10m
Patients Used
250 +
International Patents
4+
Core Technology Inside
AbstractMechanically ventilated patients with acute respiratory distress syndrome (ARDS) often receive aerosolized iloprost. Due to the short half-life of prostacyclin, extending the duration of inhalation could enhance its clinical effectiveness, though this presents technical difficulties. One potential solution is the use of inspiration-synchronized vibrating mesh nebulizers (VMNsyn), which offer high drug deposition rates and prolonged […]
Background: A breath-synchronized nebulization option that could potentially improve drug delivery during noninvasive positive pressure ventilation (NIPPV) is currently not available on single-limb circuit bilevel ventilators. The aim of this study was to compare urinary excretion of amikacin following aerosol delivery with a vibrating mesh nebulizer coupled to a single-limb circuit bilevel ventilator, using conventional […]
Introduction Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting from damage caused by harmful chemicals. These chemicals trigger a series of inflammatory responses that not only harm lung structure but also increase mucus production in the airways. COPD is characterized as a partially reversible condition with restricted airflow, leading to permanent damage […]
Together we make the world better
中国大陆
简体中文
United Kingdom
English
